128 related articles for article (PubMed ID: 8765067)
21. Serial haematology results in transfused and non-transfused dogs naturally infected with Babesia rossi.
Scheepers E; Leisewitz AL; Thompson PN; Christopher MM
J S Afr Vet Assoc; 2011 Sep; 82(3):136-43. PubMed ID: 22332296
[TBL] [Abstract][Full Text] [Related]
22. The effect of diminazene aceturate on cholinesterase activity in dogs with canine babesiosis.
Milner RJ; Reyers F; Taylor JH; van den Berg JS
J S Afr Vet Assoc; 1997 Dec; 68(4):111-3. PubMed ID: 9561493
[TBL] [Abstract][Full Text] [Related]
23. Canine babesiosis in Slovenia: molecular evidence of Babesia canis canis and Babesia canis vogeli.
Duh D; Tozon N; Petrovec M; Strasek K; Avsic-Zupanc T
Vet Res; 2004; 35(3):363-8. PubMed ID: 15210084
[TBL] [Abstract][Full Text] [Related]
24. Immunity against Babesia rossi infection in dogs vaccinated with antigens from culture supernatants.
Schetters TP; Strydom T; Crafford D; Kleuskens JA; van de Crommert J; Vermeulen AN
Vet Parasitol; 2007 Mar; 144(1-2):10-9. PubMed ID: 17056181
[TBL] [Abstract][Full Text] [Related]
25. Chemoprophylaxis with diminazene aceturate in experimental Babesia bigemina infection in cattle.
Sharma SP; Bansal GC
Res Vet Sci; 1984 Jul; 37(1):126-7. PubMed ID: 6473911
[TBL] [Abstract][Full Text] [Related]
26. A diminazene-resistant strain of Trypanosoma brucei brucei isolated from a dog is cross-resistant to pentamidine in experimentally infected albino rats.
Anene BM; Ezeokonkwo RC; Mmesirionye TI; Tettey JN; Brock JM; Barrett MP; De Koning HP
Parasitology; 2006 Jan; 132(Pt 1):127-33. PubMed ID: 16393361
[TBL] [Abstract][Full Text] [Related]
27. The effects of diminazene aceturate on systemic blood pressure in clinically healthy adult dogs.
Joubert KE; Kettner F; Lobetti RG; Miller DM
J S Afr Vet Assoc; 2003 Sep; 74(3):69-71. PubMed ID: 15029949
[TBL] [Abstract][Full Text] [Related]
28. Cerebellar ataxia as a possible complication of babesiosis in two dogs.
Jacobson LS
J S Afr Vet Assoc; 1994 Sep; 65(3):130-1. PubMed ID: 7595921
[TBL] [Abstract][Full Text] [Related]
29. The response of the pituitary-adrenal and pituitary-thyroidal axes to the plasma glucose perturbations in Babesia canis rossi babesiosis.
Schoeman JP; Herrtage ME
J S Afr Vet Assoc; 2007 Dec; 78(4):215-20. PubMed ID: 18507221
[TBL] [Abstract][Full Text] [Related]
30. Babesia canis infection in a splenectomized dog.
Camacho AT; Pallas E; Gestal JJ; Guitián FJ; Olmeda AS
Bull Soc Pathol Exot; 2002 Mar; 95(1):17-9. PubMed ID: 12012956
[TBL] [Abstract][Full Text] [Related]
31. The intravenous pharmacokinetics of diminazene in healthy dogs.
Naidoo V; Mulders MS; Swan GE
J S Afr Vet Assoc; 2009 Dec; 80(4):215-9. PubMed ID: 20458860
[TBL] [Abstract][Full Text] [Related]
32. Hematological changes during the course of canine babesiosis caused by large Babesia in domestic dogs in Warsaw (Poland).
Zygner W; Gójska O; Rapacka G; Jaros D; Wedrychowicz H
Vet Parasitol; 2007 Apr; 145(1-2):146-51. PubMed ID: 17157987
[TBL] [Abstract][Full Text] [Related]
33. Adrenal response to the low dose ACTH stimulation test and the cortisol-to-adrenocorticotrophic hormone ratio in canine babesiosis.
Schoeman JP; Herrtage ME
Vet Parasitol; 2008 Jul; 154(3-4):205-13. PubMed ID: 18468798
[TBL] [Abstract][Full Text] [Related]
34. The clinical course of babesiosis in 76 dogs infected with protozoan parasites Babesia canis canis.
Adaszek Ł; Winiarczyk S; Skrzypczak M
Pol J Vet Sci; 2009; 12(1):81-7. PubMed ID: 19459444
[TBL] [Abstract][Full Text] [Related]
35. Molecular fluorescent approach to assessing intraerythrocytic hemoprotozoan Babesia canis infection in dogs.
Bicalho KA; Ribeiro MF; Martins-Filho OA
Vet Parasitol; 2004 Nov; 125(3-4):221-35. PubMed ID: 15482880
[TBL] [Abstract][Full Text] [Related]
36. Onset and duration of immunity against Babesia canis infection in dogs vaccinated with antigens from culture supernatants.
Schetters TP; Kleuskens JA; Scholtes NC; van de Crommert J; Krijnen E; Moubri K; Gorenflot A; Vermeulen AN
Vet Parasitol; 2006 May; 138(1-2):140-6. PubMed ID: 16504401
[TBL] [Abstract][Full Text] [Related]
37. Nitric oxide metabolites in naturally occurring canine babesiosis.
Jacobson LS; Lobetti RG; Becker P; Reyers F; Vaughan-Scott T
Vet Parasitol; 2002 Feb; 104(1):27-41. PubMed ID: 11779653
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic efficacy of atovaquone against the bovine intraerythrocytic parasite, Babesia divergens.
Pudney M; Gray JS
J Parasitol; 1997 Apr; 83(2):307-10. PubMed ID: 9105316
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of efficacy of bruceine A, a natural quassinoid compound extracted from a medicinal plant, Brucea javanica, for canine babesiosis.
Nakao R; Mizukami C; Kawamura Y; Subeki ; Bawm S; Yamasaki M; Maede Y; Matsuura H; Nabeta K; Nonaka N; Oku Y; Katakura K
J Vet Med Sci; 2009 Jan; 71(1):33-41. PubMed ID: 19194074
[TBL] [Abstract][Full Text] [Related]
40. Systemic inflammatory responses in dogs experimentally infected with Babesia canis; a haematological study.
Schetters TP; Kleuskens JA; Van De Crommert J; De Leeuw PW; Finizio AL; Gorenflot A
Vet Parasitol; 2009 May; 162(1-2):7-15. PubMed ID: 19269099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
